Physician

James H Petrin, MD

According to 2025 Medicare claims, James Petrin, MD (NPI: 1316948904) practices dermatology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is SOUND DERMATOLOGY & SKIN SURGERY PLLC (NPI: 1538386990; TIN: 205823637) and primary practice location at 98052-3858.

Petrin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 479 traditional Medicare patients, billed 3,622 HCPCS/CPT codes, and received $264,345 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,625 prescription claims across 482 beneficiaries totaling $436,719 in drug costs, led by Enbrel (Etanercept). Open Payments data shows 134 records totaling $2,479. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $169,529 to $436,719. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$202K$404K2015 Medicare payment: $294,753 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $287,391 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $291,313 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $404,239 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $316,321 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $268,268 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $271,565 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $273,122 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $332,504 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $264,345 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155634,123$294,753
20165774,777$287,391
20175884,814$291,313
20186536,490$404,239
20196325,439$316,321
20205195,386$268,268
20215445,439$271,565
20225576,257$273,122
20235286,218$332,504
20244793,622$264,345

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$250K$499K2015 Drug cost: $169,529 (USD; Tot_Drug_Cst)2016 Drug cost: $161,542 (USD; Tot_Drug_Cst)2017 Drug cost: $322,313 (USD; Tot_Drug_Cst)2018 Drug cost: $342,098 (USD; Tot_Drug_Cst)2019 Drug cost: $499,122 (USD; Tot_Drug_Cst)2020 Drug cost: $298,618 (USD; Tot_Drug_Cst)2021 Drug cost: $398,261 (USD; Tot_Drug_Cst)2022 Drug cost: $343,025 (USD; Tot_Drug_Cst)2023 Drug cost: $464,903 (USD; Tot_Drug_Cst)2024 Drug cost: $436,719 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153551,303$169,529
20163431,299$161,542
20173761,482$322,313
20184221,573$342,098
20194481,600$499,122
20203901,534$298,618
20214171,597$398,261
20224091,395$343,025
20234411,532$464,903
20244821,625$436,719

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths163206$89
11102Biopsy of related skin growth, first growth158190$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more315473$67
17000Destruction of precancer skin growth, 1 growth185266$39
17003Destruction of precancer skin growth, 2-14 growths142921$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EnbrelEtanercept14392$94,396
Taltz AutoinjectorIxekizumab13364$88,461
Dupixent PenDupilumab13364$57,424
CyclosporineCyclosporine21810$12,260
Clobetasol PropionateClobetasol Propionate1845,543$7,248

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.134$2,479Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James H. Petrin, MD?

Tedicare shows public-source Medicare data for James H. Petrin, MD (NPI 1316948904), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James H. Petrin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James H. Petrin, MD?

James H. Petrin, MD is linked to SOUND DERMATOLOGY & SKIN SURGERY PLLC (billing NPI 1538386990) in the available physician profile data.

Does James H. Petrin, MD have Open Payments data?

James H. Petrin, MD has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.